Cargando…
Development of a multivariable improvement measure for gout
BACKGROUND: Gout is a heterogeneous inflammatory disease with numerous clinical manifestations. A composite means to assess the impact of therapy on numerous aspects of gout could be useful. METHODS: Results from patients treated with pegloticase or placebo in two randomized clinical trials and thei...
Autores principales: | Schlesinger, Naomi, Edwards, N. Lawrence, Yeo, Anthony E., Lipsky, Peter E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325077/ https://www.ncbi.nlm.nih.gov/pubmed/32600452 http://dx.doi.org/10.1186/s13075-020-02254-4 |
Ejemplares similares
-
Evaluation of Proposed Criteria for Remission and Evidence‐Based Development of Criteria for Complete Response in Patients With Chronic Refractory Gout
por: Schlesinger, Naomi, et al.
Publicado: (2019) -
Management of Gout in the United States: A Claims‐based Analysis
por: Edwards, N. Lawrence, et al.
Publicado: (2020) -
Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review
por: Schlesinger, Naomi, et al.
Publicado: (2023) -
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
por: Mandell, Brian F., et al.
Publicado: (2018) -
Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout
por: Calabrese, Leonard H., et al.
Publicado: (2017)